Sentinel Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-507,567
Closed -$15.1M 53
2017
Q3
$15.1M Sell
507,567
-68,830
-12% -$2.1M 0.36% 113
2017
Q2
$19.1M Sell
576,397
-77,430
-12% -$2.43M 0.46% 82
2017
Q1
$19.4M Sell
653,827
-74,571
-10% -$2.04M 0.46% 77
2016
Q4
$18.1M Sell
728,398
-29,790
-4% -$677K 0.45% 77
2016
Q3
$17.1M Buy
758,188
+20,620
+3% +$485K 0.41% 89
2016
Q2
$17.6M Buy
737,568
+147,068
+25% +$3.53M 0.41% 82
2016
Q1
$14M Buy
590,500
+56,200
+11% +$1.37M 0.31% 103
2015
Q4
$14.9M Sell
534,300
-240,300
-31% -$6.03M 0.37% 88
2015
Q3
$16M Buy
774,600
+82,200
+12% +$2.08M 0.41% 85
2015
Q2
$17.8M Sell
692,400
-113,200
-14% -$2.87M 0.41% 91
2015
Q1
$20.3M Buy
805,600
+80,900
+11% +$1.97M 0.44% 85
2014
Q4
$17.2M Buy
724,700
+34,200
+5% +$757K 0.36% 105
2014
Q3
$13.6M Buy
+690,500
New +$14.2M 0.28% 137

Other funds holding GMED

Sentinel Asset Management's GMED Position: Q4 2017 in Review

Sentinel Asset Management sold out of Globus Medical (GMED) in Q4 2017, closing a stake of 507,567 shares — an estimated $15.1M sold.

Sentinel Asset Management first reported a position in GMED in Q3 2014 and held it in 13 quarters. The position peaked at $20.3M in Q1 2015. 263 funds tracked by Wall St. Rank hold GMED as of Q4 2017.

  • Sentinel Asset Management reported no remaining Globus Medical position as of Q4 2017 after selling out during the quarter.
  • Sentinel Asset Management sold 507,567 Globus Medical shares in Q4 2017, an estimated $15.1M.
  • Sentinel Asset Management first reported a position in Globus Medical in Q3 2014 and held it in 13 quarters.
  • Sentinel Asset Management's Globus Medical position peaked at $20.3M in Q1 2015.
  • 263 funds tracked by Wall St. Rank held Globus Medical as of Q4 2017.

Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.